Imidazo[4,5-d]thiazolo[5,4-b]pyridine based inhibitors of IKK2: Synthesis, SAR, PK/PD and activity in a preclinical model of rheumatoid arthritis

The synthesis, structure–activity relationships (SAR) and biological evaluation of thiazole based tricyclic inhibitors of IKK2 are described. Compound 9 was determined to be efficacious in a murine model for rheumatoid arthritis. The synthesis, structure–activity relationships (SAR) and biological e...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2011-01, Vol.21 (1), p.383-386
Hauptverfasser: Dyckman, Alaric J., Langevine, Charles M., Quesnelle, Claude, Kempson, James, Guo, Junqing, Gill, Patrice, Spergel, Steven H., Watterson, Scott H., Li, Tianle, Nirschl, David S., Gillooly, Kathleen M., Pattoli, Mark A., McIntyre, Kim W., Chen, Laishun, McKinnon, Murray, Dodd, John H., Barrish, Joel C., Burke, James R., Pitts, William J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The synthesis, structure–activity relationships (SAR) and biological evaluation of thiazole based tricyclic inhibitors of IKK2 are described. Compound 9 was determined to be efficacious in a murine model for rheumatoid arthritis. The synthesis, structure–activity relationships (SAR) and biological evaluation of thiazole based tricyclic inhibitors of IKK2 are described. Compound 9 was determined to be orally efficacious in a murine model of rheumatoid arthritis.
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2010.10.133